Cancer Research UK logo.
SearchDonate
  • Search

A trial of idasanutlin with abiraterone or enzalutamide for men with prostate cancer who haven’t had docetaxel (MAdCaP)

Overview

Cancer types:

Prostate cancer

Status:

Closed

Phase:

Phase 1/2

Details

This trial is for men with prostate cancer that has spread and whose cancer no longer responds to hormone therapy. It is for men who haven’t had the chemotherapy drug docetaxel.

Cancer Research UK supports this trial.

Recruitment start: 4 August 2014

Recruitment end: 3 July 2017

How to join

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Rob Jones

Supported by

Cancer Research UK

NHS Greater Glasgow and Clyde

NIHR Clinical Research Network: Cancer

Roche

University of Glasgow

Other information

This is Cancer Research UK trial number CRUKE/12/032.

Last reviewed: 11 December 2022

CRUK internal database number: 10085

The Dangoor Education logo.

Dangoor Education

About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education

Patient Information Forum. Trusted Information Creator.
Plain English Campaign award.

Help and support

An icon of a hand shake.

Questions for your doctor

What to ask your doctor about clinical trials.

An icon of two speech bubbles, indicating a conversation.

Cancer chat forum

Meet and chat to other cancer people affected by cancer.

An icon of a landline phone.

Nurse helpline

Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.